Mahindra Manulife Mid Cap Fund Direct Growth

• Alpha 6.48%
• Beta 0.80
• Sharpe Ratio1.19
• Std Deviation 15.24%
• Tracking Error 7.67%

The investment objective of the Scheme is to seek to generate long term capital appreciation & provide long-term growth opportunities by investing in a portfolio constituted of equity & equity related securities and derivatives predominantly in mid cap companies.

The Mahindra Manulife Mid Cap Fund Direct Growth has an AUM of 4294.84 crores & has delivered CAGR of 24.31% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 0.45%. The minimum investment in Mahindra Manulife Mid Cap Fund Direct Growth is Rs 1000 and the minimum SIP is Rs 500.

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

The top holdings of the fund include Glenmark Pharmaceuticals, Indian Bank, Max Financial Services & Federal Bank.

The major sectors where the fund is invested are Regional Banks, Misc. Capital Goods, Biotechnology & Drugs & Consumer Financial Services.

Some of the similar funds are Mahindra Manulife Mid Cap Fund Direct Growth, Tata Mid Cap Fund Direct Plan Growth, Baroda BNP Paribas Mid Cap Fund Direct Plan Growth Option, WhiteOak Capital Mid Cap Fund Direct Growth, Canara Robeco Mid Cap Fund Direct Growth. Mahindra Manulife Mid Cap Fund Direct Growth has a sharpe ratio of 1.19 & a standard deviation of 15.24%.